Farmington Hills, Mich., October 31, 2023 ̶ Quest Research Institute, part of the Alcanza Clinical Research site network, today announced the opening of a new research facility, increasing its capacity…
Read More
Meet Dan, Citizen Scientist Elevated Honoree! Dan was presented his award at the GAP-Net Site Optimization Conference in Scottsdale AZ! This is a time for the GAP team, the QUEST...
Read More
QUEST Research was selected to be one of 90 sites worldwide to join the GAP-Net network of clinical research sites. GAP-Net sites benefit from sharing knowledge and experience in order to...
Read More
QUEST Research's Dolly Niles and Dr. Aaron Ellenbogen joined forces to present a Lunch & Learn session to HBEC on memory health and the importance of minority participation in research...
Read More
Watch QUEST Research's Michael J. Fox Foundation and Team Fox in the D “Research Roundtable” presentation with Dr. Aaron Ellenbogen, Investigator at QUEST and Dr. Bradford Casey from the MJF...
Read More
Source: Prothena Corporation PLC First potentially disease-modifying anti-alpha-synuclein antibody to be evaluated for efficacy in patients with Parkinson’s disease Prothena to receive $30 million milestone payment under collaboration agreement with Roche…
